Widespread Repression of Gene Expression in Cancer by a Wnt/β-Catenin/MAPK Pathway

Nathan Harmston1,2, Jun Yi Stanley Lim1, Oriol Arqués3

  • 1Program in Cancer and Stem Cell Biology, Duke-NUS Medical School, Singapore.

Cancer Research
|November 18, 2020
PubMed

Insights

Aberrant Wnt signaling in cancer represses MAPK activity, promoting proliferation. Inhibiting Wnt signaling activates MAPK, revealing a dual role in gene regulation and cancer growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Pathways

Background:

  • Aberrant Wnt signaling is a known driver of various cancers, influencing proto-oncogenes like MYC and cyclins.
  • Previous understanding focused on Wnt/β-catenin's role in gene activation, but its broader transcriptomic impact was unclear.

Purpose of the Study:

  • To investigate genes upregulated upon Wnt signaling inhibition in pancreatic and colorectal cancer models.
  • To elucidate the role of Wnt signaling in repressing MAPK activity and its implications for cancer proliferation.

Main Methods:

  • Examined gene expression changes in response to Wnt signaling inhibition in cancer models.
  • Assessed the impact of concurrent MEK inhibition on Wnt-mediated gene expression changes.

Main Results:

  • Inhibition of Wnt signaling led to increased gene expression via activation of ERK and JNK pathways.
  • Concurrent MEK inhibition partially reversed these gene expression changes.
  • Wnt signaling was found to repress MAPK activity, preventing RAS-mediated senescence and promoting cancer cell proliferation.

Conclusions:

  • Wnt/β-catenin signaling plays a dual role, activating some genes while repressing others, including those involved in MAPK signaling.
  • Wnt signaling fine-tunes the RAS-MAPK pathway to optimize cancer cell proliferation by suppressing senescence.
  • This study reframes Wnt/β-catenin signaling as a critical regulator of both gene activation and repression in cancer.

Related Concept Videos

Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
8.0K
Catenins01:23

Catenins

Catenins are characterized by multiple binding domains and dynamic structures that allow them to function as linker proteins in cell junction complexes. All catenins, except α-catenin, contain a characteristic protein sequence called the armadillo repeat and are therefore also called armadillo proteins.
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the...
2.8K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.9K